Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

BUY
$2.21 - $3.22 $11,050 - $16,100
5,000 Added 5.79%
91,400 $214,000
Q2 2021

Aug 13, 2021

SELL
$2.61 - $4.17 $36,540 - $58,380
-14,000 Reduced 13.94%
86,400 $289,000
Q1 2021

May 14, 2021

BUY
$2.91 - $4.32 $237,165 - $352,080
81,500 Added 431.22%
100,400 $312,000
Q4 2020

Feb 12, 2021

BUY
$2.15 - $3.5 $40,635 - $66,150
18,900 New
18,900 $52,000

Others Institutions Holding VBIV

About VBI Vaccines Inc


  • Ticker VBIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 258,256,992
  • Market Cap $5.17M
  • Description
  • VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...
More about VBIV
Track This Portfolio

Track Mml Investors Services, LLC Portfolio

Follow Mml Investors Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mml Investors Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mml Investors Services, LLC with notifications on news.